ARTICLE | Distillery Therapeutics
Cancer
November 8, 2017 5:07 PM UTC
In vitro, cell culture, patient sample and mouse studies identified a heterocyclic diamidine-based inhibitor of the SPI1-DNA interaction that could help treat AML. Chemical synthesis and in vitro bind...
BCIQ Target Profiles